Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), Monopar Therapeutics Inc (NASDAQ:MNPR), Altimmune Inc (NASDAQ:ALT), Prothena Corp PLC (NASDAQ:PRTA) and ADC Therapeutics SA (NYSE:ADCT).
Bicycle Therapeutics has a consensus price target of $24.75.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $7.4 last updated December 15, 2025 at 7:51 AM EST.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.